Mereo BioPharma Group Stock (NASDAQ: MREO) stock price, news, charts, stock research, profile.
Open | $2.750 |
Close | $2.810 |
Volume / Avg. | 1.031M / 1.502M |
Day Range | 2.640 - 2.820 |
52 Wk Range | 0.920 - 4.360 |
Market Cap | $394.123M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 42 |
Short Interest | 2.01% |
Days to Cover | 2.08 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Mereo BioPharma Group (NASDAQ: MREO) through any online brokerage.
Other companies in Mereo BioPharma Group’s space includes: Skye Bioscience (NASDAQ:SKYE), Precigen (NASDAQ:PGEN), Voyager Therapeutics (NASDAQ:VYGR), Larimar Therapeutics (NASDAQ:LRMR) and PepGen (NASDAQ:PEPG).
The latest price target for Mereo BioPharma Group (NASDAQ: MREO) was reported by Needham on Wednesday, April 10, 2024. The analyst firm set a price target for 6.00 expecting MREO to rise to within 12 months (a possible 113.52% upside). 9 analyst firms have reported ratings in the last year.
The stock price for Mereo BioPharma Group (NASDAQ: MREO) is $2.81 last updated April 25, 2024 at 5:27 PM EDT.
There are no upcoming dividends for Mereo BioPharma Group.
Mereo BioPharma Group’s FY earnings are confirmed for Wednesday, March 27, 2024.
There is no upcoming split for Mereo BioPharma Group.
Mereo BioPharma Group is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.